The plaque psoriasis industry has witnessed robust growth driven by increasing awareness, technological advances, and expanding treatment options. This market continues to evolve dynamically, reflecting significant opportunities for business growth and medical innovation across global markets.
Market Size and Overview
The Plaque Psoriasis Market is estimated to be valued at USD 32.28 Bn in 2025 and is expected to reach USD 52.17 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032.
This notable market growth is supported by rising patient populations, improved diagnostic capabilities, and diversified pharmaceutical offerings creating a positive market forecast for stakeholders. Increasing adoption of biologic therapies is a key contributor to the expanding industry size and Plaque Psoriasis Market Revenue globally.
Market Drivers
One key market driver shaping the plaque psoriasis market growth is the increasing prevalence of psoriasis and patient access to novel therapies. According to recent 2024 epidemiological data, more than 125 million people worldwide suffer from psoriasis, with plaque psoriasis comprising approximately 80% of cases.
Innovations such as interleukin inhibitors and Janus kinase (JAK) inhibitors launched in late 2024 have significantly improved clinical outcomes, fueling market growth. For example, targeted biologics introduced by leading market players contributed to over 15% of incremental revenue in developed markets in 2025, reflecting strong market demand and evolving treatment standards.
PEST Analysis
- Political: In 2025, several governments introduced favorable policies and reimbursement frameworks to support access to advanced psoriasis treatments, increasing market scope and industry share by reducing cost barriers. Regulatory agencies in the U.S. and Europe fast-tracked approvals, accelerating market growth strategies.
- Economic: The steady rise in healthcare spending in emerging economies boosted market revenue, as these regions invest in healthcare infrastructure, increasing access to psoriasis therapies and expanding market segments with a growing middle-class patient base in 2024-2025.
- Social: Growing awareness campaigns and patient advocacy initiatives launched in 2024 heightened public understanding of plaque psoriasis, supporting earlier diagnosis and improving patient adherence to treatments, thus positively impacting market dynamics and business growth.
- Technological: Technological advances in drug delivery systems, including biosimilars and digital health monitoring tools introduced in 2025, have enhanced treatment efficacy and patient convenience, driving innovation and competitive differentiation within market companies.
Promotion and Marketing Initiatives
In 2025, a key marketing initiative was observed when a leading pharmaceutical company executed a digital awareness campaign targeting social media channels to educate patients and healthcare providers about emerging plaque psoriasis therapies. This campaign resulted in a 20% increase in engagement and a 12% rise in prescription rates within six months, showcasing the effectiveness of integrated digital promotion in expanding market opportunities and strengthening industry trends.
Key Players
- AbbVie Inc.
- Novartis International AG
- Johnson & Johnson (Janssen Pharmaceuticals)
- Eli Lilly and Company
- Amgen Inc.
Recent strategies by these market players in 2024-2025 include:
- AbbVie Inc. expanded its biologics portfolio with the 2025 launch of a next-generation IL-23 inhibitor, significantly enhancing its market share in North America and Europe.
- Novartis International AG established new manufacturing facilities in Asia in early 2024, incrementing production capacity and reducing supply chain challenges to capture emerging markets.
- Johnson & Johnson entered a strategic partnership with a biotech startup in 2025 focusing on oral small-molecule therapies, projecting increased market revenue by 2027.
- Eli Lilly and Company enhanced its digital patient support programs in 2024, integrating AI-based adherence tools that improved treatment compliance rates.
- Amgen Inc. launched a biosimilar plaque psoriasis biologic in late 2024, successfully penetrating price-sensitive markets and contributing to a 10% growth in market revenue.
FAQs
1. Who are the dominant players in the Plaque Psoriasis market?
Leading companies include AbbVie, Novartis, Johnson & Johnson (Janssen Pharmaceuticals), Eli Lilly, and Amgen, all of whom have introduced innovative therapies and strategic partnerships recently.
2. What will be the size of the Plaque Psoriasis market in the coming years?
The market is forecasted to grow from USD 32.28 billion in 2026 to USD 52.17 billion by 2033, reflecting robust growth and expanding patient access to advanced treatments.
3. Which end-user industry has the largest growth opportunity?
The pharmaceutical sector targeting chronic autoimmune diseases represents the largest growth opportunity, driven by expanding biologic therapy adoption and rising healthcare investments.
4. How will market development trends evolve over the next five years?
Key trends involve increased integration of digital health tools, expansion of biosimilar offerings, and improved reimbursement policies that together will augment the Plaque Psoriasis market revenue and business growth.
5. What is the nature of the competitive landscape and challenges in the Plaque Psoriasis market?
The competitive landscape is marked by intense innovation and pricing pressures, with challenges including regulatory hurdles and the need for continuous product differentiation amid growing generic competition.
6. What go-to-market strategies are commonly adopted in the Plaque Psoriasis market?
Market players leverage product innovation, strategic partnerships, digital marketing, and patient support programs to expand market share and capitalize on emerging market segments.
➣ Get more insights on : Plaque Psoriasis Market
➣ Get this Report in Japanese Language: 尋常性乾癬市場
➣ Get this Report in Korean Language: 플라크건선시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.